Insider · CIK 0001598602
Daws D. Ryan
Reports to the SEC for 2 companies · SAINT-LAURENT, A8
Transactions
6
Companies
2
Filings
6
CIK
0001598602
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-30 | ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-01-29 | ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-11-30 | ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-01-04 | CONCERT PHARMACEUTICALS, INC.Employee Stock Option (right to buy)A Award | — |
| 2016-01-07 | CONCERT PHARMACEUTICALS, INC.Employee Stock Option (right to buy)A Award | — |
| 2014-02-19 | CONCERT PHARMACEUTICALS, INC.Employee Stock Option (right to buy)A Award | — |
Recent filings
- 4Daws D. Ryan0000929638-26-000481SEC(opens sec.gov)
- 4Daws D. Ryan0000929638-25-000478SEC(opens sec.gov)
- 4Daws D. Ryan0000929638-23-003339SEC(opens sec.gov)
- 4CONCERT PHARMACEUTICALS, INC.0001209191-17-002680SEC(opens sec.gov)
- 4CONCERT PHARMACEUTICALS, INC.0001209191-16-090567SEC(opens sec.gov)
- 4CONCERT PHARMACEUTICALS, INC.0001209191-14-011854SEC(opens sec.gov)
Companies
Address
C/O 4868 RUE LEVY, SUITE 220
SAINT-LAURENT, A8, H4R 2P1